Renaissance Technologies’s Compass Therapeutics CMPX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$584K Sell
224,600
-96,900
-30% -$252K ﹤0.01% 2759
2025
Q1
$611K Buy
321,500
+42,900
+15% +$81.5K ﹤0.01% 2659
2024
Q4
$404K Buy
278,600
+56,000
+25% +$81.2K ﹤0.01% 2947
2024
Q3
$410K Buy
222,600
+82,000
+58% +$151K ﹤0.01% 2865
2024
Q2
$141K Buy
140,600
+70,200
+100% +$70.2K ﹤0.01% 3119
2024
Q1
$139K Sell
70,400
-106,399
-60% -$210K ﹤0.01% 3302
2023
Q4
$276K Buy
176,799
+149,999
+560% +$234K ﹤0.01% 3016
2023
Q3
$53K Buy
+26,800
New +$53K ﹤0.01% 3392
2023
Q2
Sell
-52,300
Closed -$171K 3958
2023
Q1
$171K Buy
52,300
+400
+0.8% +$1.31K ﹤0.01% 3336
2022
Q4
$261K Sell
51,900
-12,315
-19% -$61.9K ﹤0.01% 3291
2022
Q3
$146K Sell
64,215
-1,950
-3% -$4.43K ﹤0.01% 3487
2022
Q2
$175K Buy
66,165
+52,865
+397% +$140K ﹤0.01% 3697
2022
Q1
$18K Buy
+13,300
New +$18K ﹤0.01% 4011